Homoeopathic versus conventional treatment of children with eczema: A comparative cohort study

Complementary Therapies in Medicine

Volumn 16, Issue 1, 2008, Pages 15-21

  Keil, T ^a   Witt, C M ^a   Roll, S ^a   Vance, W ^a   Weber, K ^a   Wegscheider, K ^b   Willich, S N ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Atopic dermatitis; Atopic eczema; Cohort study; Homoeopathy

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECZEMA; FEMALE; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SYMPTOM;

CHILD; CHILD, PRESCHOOL; ECZEMA; FEMALE; HOMEOPATHY; HUMANS; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 40649099595     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2006.10.001     Document Type: Article

References (34)

1. Leung D.Y., Diaz L.A., DeLeo V., and Soter N.A. Allergic and immunologic skin disorders. JAMA 278 (1997) 1914-1923
2. Hoare C., Wan Po A.L., and Williams H. Systematic review of treatment of atopic eczema. Health Technol Assess (2000) 37
3. Johansson S.G., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F., et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113 (2004) 832-836
4. Williams H.C. Is the prevalence of atopic dermatitis increasing?. Clin Exp Dermatol 17 (1992) 385-391
5. Williams H.C. Atopic dermatitis: the epidemiology, causes and prevention of atopic eczema (2000), Cambridge University Press, Cambridge
6. Herd R.M. The morbidity and cost of atopic dermatitis. In: Williams H.C. (Ed). Atopic dermatitis (2000), Cambridge University Press, Cambridge 85-95
7. Granlund H. Treatment of childhood eczema. Paediatr Drugs 4 (2002) 729-735
8. Schiffner R., Schiffner-Rohe J., Landthaler M., and Stolz W. Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids. Pharmacoeconomics 21 (2003) 159-179
9. Emerson R.M., Williams H.C., and Allen B.R. What is the cost of atopic dermatitis in preschool children?. Br J Dermatol 144 (2001) 514-522
10. Leung D.Y., Hanifin J.M., Charlesworth E.N., Li J.T., Bernstein I.L., Berger W.E., et al. Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Work Group on Atopic Dermatitis. Ann Allergy Asthma Immunol 79 (1997) 197-211
11. Perry T.T., and Wood R.A. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatrics 112 (2003) 462
12. Wahn U., Bos J.D., Goodfield M., Caputo R., Papp K., Manjra A., et al. Flare reduction in eczema with elidel (Children) Multicenter Investigator Study Group. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 110 (2002) e2
13. Whalley D., Huels J., McKenna S.P., and Van A.D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis. Pediatrics 110 (2002) 1133-14136
14. Eichenfield L.F., Hanifin J.M., Beck L.A., Lemanske Jr. R.F., Sampson H.A., Weiss S.T., et al. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics 111 (2003) 608-616
15. Schäfer T., Riehle A., Wichmann H.E., and Ring J. Alternative medicine in allergies-prevalence, patterns of use, and costs. Allergy 57 (2002) 694-700
16. Jensen P. Alternative medicine and chronic skin disease. Use of alternative treatments among patients with atopic eczema and psoriasis. Tidsskr Nor Laegeforen 110 (1990) 2869-2872
17. Becker-Witt C., Lüdtke R., Weisshuhn T.E., and Willich S.N. Diagnoses and treatment in homeopathic medical practice. Forsch Komplementärmed Klass Naturheilkd 11 (2004) 98-103
18. Linde K., Clausius N., Ramirez G., Melchart D., Eitel F., Hedges L.V., et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 350 (1997) 834-843
19. Siebenwirth J.A. A randomized, placebo controlled, double-blind study testing the effectiveness of classical homeopathic therapy of atopic dermatitis (AD). In: Walach H., et al. (Ed). Future directions and current issues of research in homeopathy (2002), Samueli Institute for Information Biology, Freiburg 79-90
20. Witt C., Keil T., Selim D., Roll S., Vance W., Wegscheider K., et al. Outcome and costs of homoeopathic and conventional treatment strategies: A comparative cohort study in patients with chronic disorders. Complement Ther Med 13 (2005) 79-86
21. Williams H.C., Burney P.G., Hay R.J., Archer C.B., Shipley M.J., Hunter J.J., et al. The U. K. Working Party's Diagnostic Criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131 (1994) 383-396
22. Williams H.C., Burney P.G., Strachan D., and Hay R.J. The U.K. Working Party's diagnostic criteria for atopic dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 131 (1994) 397-405
23. Haucke K. Entwicklung und Validierung eines Atopie-Lebensqualitätsfragebogens für Kinder. Charité University Medical Center Berlin; 2004 [dissertation].
24. Ravens-Sieberer U., and Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 7 (1998) 399-407
25. Wittorff M. KITA Fragebogen zur Erfassung der gesundheitsbezogenen Lebensqualität von Kleinkindern zwischen 1-6 Jahren. Charité University Medical Center Berlin; 2002 [dissertation].
26. Scott J., and Huskisson E.C. Vertical or horizontal visual analogue scales. Ann Rheum Dis 38 (1979) 560
27. Correale C.E., Walker C., Murphy L., and Craig T.J. Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician 60 (1999) 1191-1210
28. Sampson H.A., and Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 74 (1984) 26-33
29. Hoffman D.R. Specific IgE antibodies in atopic eczema. J Allergy Clin Immunol 55 (1975) 256-267
30. Blaiss M.S. Outcomes analysis in asthma. JAMA 278 (1997) 1874-1880
31. King R.M., and Wilson G.V. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res 35 (1991) 697-706
32. Hanifin J.M., Thurston M., Omoto M., Cherill R., Tofte S.J., and Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 10 (2001) 11-18
33. Kunz B., Oranje A.P., Labreze L., Stalder J.F., Ring J., and Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on atopic dermatitis. Dermatology 195 (1997) 10-19
34. Gelmetti C., and Colonna C. The value of SCORAD and beyond. Towards a standardized evaluation of severity?. Allergy 59 (2004) 61-65